Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06219967
Other study ID # 1783698-11
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date January 4, 2023
Est. completion date March 14, 2023

Study information

Verified date May 2024
Source State University of New York - Upstate Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Activated charcoal (AC) is an established, effective means of gastrointestinal decontamination. Providers give it to patients who have ingested something that is thought to be potentially poisonous to prevent it from being absorbed. However, one limitation to its use is palatability of the AC for the patient, potentially limiting how much, if any, is taken. Other studies have suggested that mixing AC with various substances improves the rating on various scales (taste, etc). An important question is whether mixing the AC with other substance effects the ability of the AC to bind to xenobiotic in the gut. This small study investigates whether mixed cola with charcoal affected its ability to prevent the absorption of acetaminophen. It also performs a survery to see if participants preferred the AC-cola mixture. The investigators hypothesize that the AC will be equally as effective with cola as without. The investigators also hypothesize that participants will prefer the AC-cola mixture.


Recruitment information / eligibility

Status Completed
Enrollment 5
Est. completion date March 14, 2023
Est. primary completion date March 14, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - No self-reported history of any hepatic, gastrointestinal, or renal disease - No self-reported history of alcohol or substance use disorder - No daily prescribed medications - Weight between 60-93 kg Exclusion Criteria: - pregnant, - imprisoned - allergy or intolerance to acetaminophen or gluten

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Activated Charcoal
Activated charcoal alone
Activated Charcoal
Activated charcoal mixed with cola

Locations

Country Name City State
United States SUNY Upstate Medical University Clinical Research Unit Syracuse New York

Sponsors (1)

Lead Sponsor Collaborator
State University of New York - Upstate Medical University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Absorption of Acetaminophen as Indicated by Area Under the Curve Measure of the area under the curve of the acetaminophen concentration vs time curve. Values obtained at 0, 15, 30, 45, 60, 75, 90, 120, 180, and 240 minutes were used to produce the curve 240 minutes
Primary Maximum Concentration Acetaminophen Maximum concentration of acetaminophen (mcg/mL) 240 minutes
Primary Time to Maximum Concentration of Acetaminophen Time of maximum concentration of acetaminophen (minutes) 240 minutes
Secondary Appeal of Charcoal Mixture Participant rating of the appearance of charcoal mixture on a scale of 0 to 10, with 10 being the most appealing and 0 being the least appealing 5 minutes
Secondary Smell of Charcoal Mixture Participant rating of the smell of charcoal mixture on a scale of 0 to 10, with 10 being the most appealing and 0 being the least appealing 5 minutes
Secondary Flavor of Charcoal Mixture Participant rating of the flavor of charcoal mixture on a scale of 0 to 10, with 10 being the most appealing and 0 being the least appealing 5 minutes
Secondary Texture of Charcoal Mixture Participant rating of the texture of charcoal mixture on a scale of 0 to 10, with 10 being the most appealing and 0 being the least appealing 5 minutes
Secondary Overall Appeal of Charcoal Mixture Participant rating of the overall appeal of charcoal mixture on a scale of 0 to 10, with 10 being the most appealing and 0 being the least appealing 5 minutes
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05786222 - Permanent Supportive Housing Overdose Prevention N/A
Completed NCT02282306 - Phone Interview to Prevent Recurring Opioid Overdoses N/A
Completed NCT01050270 - Scottish and Newcastle Anti-emetic Pre-treatment for Paracetamol Poisoning Study (SNAP) Phase 4
Recruiting NCT05343169 - Community-based Education, Navigation, and Support Intervention for Military Veterans N/A
Completed NCT03482232 - Consequences of Doing What Should Not be Done in Primary Care
Completed NCT03402672 - AWAITS: A Web-based E-health Application for Active Illicit Opioid Users N/A
Completed NCT03337100 - The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy N/A
Enrolling by invitation NCT05776823 - Pharmacist-Led Interventions to Increase Access to Medications for Opioid Use Disorders (PLI-MOUD) N/A
Not yet recruiting NCT06316739 - The Ganchero Intervention for Migrant People Who Inject Drugs From Puerto Rico in New York City N/A
Completed NCT03107689 - Prospective Cohort Study of Intravenous Lipid Emulsion for Resuscitating Critically-ill Poisoned Patients
Completed NCT02101424 - Monitoring of Overdose Patients With and Without Supplemental Oxygen in the Emergency Department N/A
Completed NCT03518021 - Naloxone Nasal Spray Compared With Naloxone Injection for Opioid Overdoses Outside the Hospital Phase 3
Not yet recruiting NCT06236087 - Overdose Prevention Centers and Behavioral Health
Completed NCT04212364 - An Evaluation of a Social Network Intervention for Primary and Secondary Prevention of Opioid Overdoses N/A
Completed NCT04953338 - Mental Health Associations With Vitiligo
Active, not recruiting NCT06456294 - Evaluation of a Medication Health Center to Promote Opioid Safety N/A
Completed NCT03908437 - Rapid Initiation of Drug Treatment Engagement Phase 4
Recruiting NCT05886712 - Improving Equitable Access to Naloxone to Prevent Opioid Overdose Deaths Within Syringe Service Programs (SAIA-Naloxone) N/A
Completed NCT04797221 - Emergency Room Firearm and Medication Safety Intervention
Recruiting NCT06216327 - Safety Planning 6+ N/A